The most satisfying experiences for me include working in a collaborative way with emerging life sciences and technology company clients to help them reach a goal or achieve success. Occasionally, that includes opportunities to work with clients as they hit a home run, which is always a thrill, but simply helping clients realize their goals and form and carry out their business plans is also gratifying.
- Represented Ophthotech in its $1 billion-plus collaboration transaction with Novartis for the development and commercialization of Ophthotech’s Fovista product outside the United States and in Ophthotech’s $175 million financing transaction with Novo A/S to support development of Fovista.
- Represented Mitobridge in its $730 million R&D collaboration and transaction with Astellas.
- Other recent representations include collaboration and licensing matters for Adimab, Concert Pharmaceuticals, Epizyme, Merrimack Pharmaceuticals and Spark Therapeutics, among others.
Daily Reads: The New York Times
Favorite Books: The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee, historical fiction, mysteries, action and suspense, and Harry Potter.
Off the Clock: Playing paddle tennis and golf, hiking, traveling, watching and attending sporting events, and parenting twin teenagers.
JD, University of Michigan Law School, 1996
MBA, University of Michigan, 1996
SB, Mechanical Engineering, Massachusetts Institute of Technology, 1989
Bar AdmissionsMassachusettsMichiganUnited States Patent and Trademark Office
Technology Transactions and Licensing
Life Sciences: Medical Devices, Biotech, Pharmaceutical
Technology: Mobile, Telecom, Infrastructure, Software (includes SAAS and Cloud computing), Healthcare IT, Services